Laddar...
Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders
Enzyme replacement therapies for lysosomal storage disorders are often hindered by suboptimal biodistribution of recombinant enzymes after systemic injection. This is the case for Pompe disease caused by acid α-glucosidase (GAA) deficiency, leading to excess glycogen storage through the body, mainly...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2011
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3279604/ https://ncbi.nlm.nih.gov/pubmed/21906578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2011.08.014 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|